Evidence map›Paper›PMID 32595499›Full record

ArticleFrontiers in pharmacology2020

Treatment of Experimental Cerebral Malaria by Slow Release of Artemisone From Injectable Pasty Formulation.

Jacob Golenser, Nadeen Salaymeh, Abd Alroof Higazi, Mohammed Alyan, Mahran Daif, Ron Dzikowski, Abraham J Domb

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Frontiers in pharmacology, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
2.2field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 15 citations in OpenAlex.

  1. Review
  2. Exploring adjunctive therapies for cerebral malaria.Frontiers in cellular and infection microbiology · 2024
    Review
  3. Applicability of Redirecting Artemisinins for New Targets.Global challenges (Hoboken, NJ) · 2023
    Review
  4. Review
  5. Review
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 1 country.

Jacob GolenserDepartment of Microbiology and Molecular Genetics, The Kuvin Centre for the Study of Infectious and Tropical Diseases, Faculty of Medicine, the Hebrew University (HU), Jerusalem, Israel.
Nadeen SalaymehDepartment of Microbiology and Molecular Genetics, The Kuvin Centre for the Study of Infectious and Tropical Diseases, Faculty of Medicine, the Hebrew University (HU), Jerusalem, Israel.
Abd Alroof HigaziClinical Microbiology, the Hadassah Hospital, Jerusalem, Israel.
Mohammed AlyanDepartment of Microbiology and Molecular Genetics, The Kuvin Centre for the Study of Infectious and Tropical Diseases, Faculty of Medicine, the Hebrew University (HU), Jerusalem, Israel.
Mahran DaifFaculty of Medicine, School of Pharmacy, Institute of Drug Research, HU, Jerusalem, Israel.
Ron DzikowskiDepartment of Microbiology and Molecular Genetics, The Kuvin Centre for the Study of Infectious and Tropical Diseases, Faculty of Medicine, the Hebrew University (HU), Jerusalem, Israel.
Abraham J DombFaculty of Medicine, School of Pharmacy, Institute of Drug Research, HU, Jerusalem, Israel.
Hebrew University of Jerusalem · ILHerzog Hospital · IL

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Malaria caused by

Indexed as

artemisonecerebral malariapasty polymer formulationPlasmodiumslow release

Identifiers

PMID32595499
PMCPMC7303303
OpenAlexW3035089998

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.